Covaxin single-dose for survivor may be as effective as both for uninfected

According to a pilot study by ICMR (Indian Council for Medical Research) a single dose of Bharat Biotech’s Covaxin in people who have been infected with the virus has a response that is similar to that provided by two doses of the vaccine in those without any history of the infection.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3sTDv2Z
via IFTTT